GSK NEWSROOM (405 press releases)
Advanced Filtering & Sorting Options:
PRESS RELEASE -- 29, November 2017
Regulatory milestone affirms GSK’s strong commitment and scientific capabilities to fighting infectious diseases LONDON/GENEVA, 29-Nov-2017 — /EuropaWire/ — GSK and Medicines for Malaria Venture (MMV) today announced the submission of a new drug application (NDA) by GSK to the United States …
Read the full press release →PRESS RELEASE -- 29, November 2017
LONDON, 29-Nov-2017 — /EuropaWire/ — Responding to the launch of the Industrial Strategy White Paper, published today by the UK Government, Phil Thomson, President, Global Affairs, at GSK said: “A new, long-term industrial strategy for the country is important and welcome. We …
Read the full press release →PRESS RELEASE -- 29, November 2017
The ATLAS-2M study will evaluate injections every two months in virally suppressed patients LONDON, 29-Nov-2017 — /EuropaWire/ — Today (27 November 2017) ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, …
Read the full press release →PRESS RELEASE -- 14, September 2017
LONDON, 14-Sep-2017 — /EuropaWire/ — GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support the efficacy and safety of Shingrix …
Read the full press release →PRESS RELEASE -- 19, June 2017
Final efficacy and safety results from phase II continuation study Madrid, Spain and London, UK, 19-Jun-2017 — /EuropaWire/ — GSK today announced results from a 10-year continuation study, which showed that Benlysta (belimumab) plus standard of care prolonged control of disease …
Read the full press release →PRESS RELEASE -- 18, April 2017
NOTTINGHAM, 18-Apr-2017 — /EuropaWire/ — A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline (GSK). The MyAsthma app has been launched …
Read the full press release →PRESS RELEASE -- 12, April 2017
LONDON, 12-Apr-2017 — /EuropaWire/ — GSK keeps its financial reporting framework under regular review to ensure that it remains current and in line with both the latest regulatory requirements and developing best practice within the Pharmaceutical industry. As a result of …
Read the full press release →PRESS RELEASE -- 27, February 2017
SWINDON, 27-Feb-2017 — /EuropaWire/ — A major new £100 million investment by the government into the development of an innovative multi-disciplinary science and technology research centre was announced today (Thursday 23 February 2017) by Business Secretary Greg Clark. The new Rosalind …
Read the full press release →PRESS RELEASE -- 28, October 2016
The World Economic Forum’s Global Gender Gap Report 2016 finds economic parity between the sexes could take 170 years after a dramatic slowdown in progress Slowdown partly down to chronic imbalances in salaries and labour force participation, despite the fact …
Read the full press release →PRESS RELEASE -- 4, October 2016
PARIS, 04-Oct-2016 — /EuropaWire/ — Sanofi today announced the appointment of Alan Main as Executive Vice President Consumer HealthCare, effective October 1st, 2016. Mr. Main will be a member of the Executive Committee and lead a newly created Consumer Healthcare …
Read the full press release →PRESS RELEASE -- 29, September 2016
LONDON, 29-Sep-2016 — /EuropaWire/ — GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately. He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty as …
Read the full press release →